No Data
No Data
Savara Announces New Employment Inducement Grant
Savara Initiates Early Access Program for Rare Lung Disease Treatment
Express News | Savara Inc: Plans to Complete Submission of a Bla to FDA for Molgramostim in Apap in H1 of 2025
Express News | Savara : Savara Early Access Accepting Requests From Patients in Select Countries in N.america & Europe, Plans to Expand Through 2026
Express News | Savara Announces Expanded Access Program (Eap) for Molgramostim Inhalation Solution (Molgramostim) for Patients With Autoimmune Pulmonary Alveolar Proteinosis (Apap)
Savara Announces Expanded Access Program (EAP) for Molgramostim Inhalation Solution (Molgramostim) for Patients With Autoimmune Pulmonary Alveolar Proteinosis (APAP)
No Data
No Data